Report cover image

Global Home Parenteral Nutrition (HPN) Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 199 Pages
SKU # APRC20360065

Description

Summary

According to APO Research, the global Home Parenteral Nutrition (HPN) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Home Parenteral Nutrition (HPN) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Home Parenteral Nutrition (HPN) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Home Parenteral Nutrition (HPN) market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Home Parenteral Nutrition (HPN) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Home Parenteral Nutrition (HPN) market include B. Braun Melsungen, Grifols International, Otsuka Pharmaceutical, Sichuan Kelun Pharmaceutical, Teva Pharmaceutical, Baxter, Fresenius Kabi, Pfizer and Takeda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Home Parenteral Nutrition (HPN), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Home Parenteral Nutrition (HPN), also provides the sales of main regions and countries. Of the upcoming market potential for Home Parenteral Nutrition (HPN), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Home Parenteral Nutrition (HPN) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Home Parenteral Nutrition (HPN) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Home Parenteral Nutrition (HPN) sales, projected growth trends, production technology, application and end-user industry.

Home Parenteral Nutrition (HPN) Segment by Company

B. Braun Melsungen
Grifols International
Otsuka Pharmaceutical
Sichuan Kelun Pharmaceutical
Teva Pharmaceutical
Baxter
Fresenius Kabi
Pfizer
Takeda
Home Parenteral Nutrition (HPN) Segment by Type

Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Carbohydrates
Trace Elements
Vitamins and Minerals
Home Parenteral Nutrition (HPN) Segment by Application

Neonates
Chronic Disease Patients
Geriatrics
Home Parenteral Nutrition (HPN) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Home Parenteral Nutrition (HPN) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Home Parenteral Nutrition (HPN) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Home Parenteral Nutrition (HPN) significant trends, drivers, influence factors in global and regions.
6. To analyze Home Parenteral Nutrition (HPN) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Parenteral Nutrition (HPN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Parenteral Nutrition (HPN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Parenteral Nutrition (HPN).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Parenteral Nutrition (HPN) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Home Parenteral Nutrition (HPN) industry.
Chapter 3: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Home Parenteral Nutrition (HPN) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
1.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume (2020-2031)
1.2.3 Global Home Parenteral Nutrition (HPN) Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Home Parenteral Nutrition (HPN) Market Dynamics
2.1 Home Parenteral Nutrition (HPN) Industry Trends
2.2 Home Parenteral Nutrition (HPN) Industry Drivers
2.3 Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges
2.4 Home Parenteral Nutrition (HPN) Industry Restraints
3 Home Parenteral Nutrition (HPN) Market by Company
3.1 Global Home Parenteral Nutrition (HPN) Company Revenue Ranking in 2024
3.2 Global Home Parenteral Nutrition (HPN) Revenue by Company (2020-2025)
3.3 Global Home Parenteral Nutrition (HPN) Sales Volume by Company (2020-2025)
3.4 Global Home Parenteral Nutrition (HPN) Average Price by Company (2020-2025)
3.5 Global Home Parenteral Nutrition (HPN) Company Ranking (2023-2025)
3.6 Global Home Parenteral Nutrition (HPN) Company Manufacturing Base and Headquarters
3.7 Global Home Parenteral Nutrition (HPN) Company Product Type and Application
3.8 Global Home Parenteral Nutrition (HPN) Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Home Parenteral Nutrition (HPN) Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Home Parenteral Nutrition (HPN) Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Home Parenteral Nutrition (HPN) Market by Type
4.1 Home Parenteral Nutrition (HPN) Type Introduction
4.1.1 Parenteral Lipid Emulsion
4.1.2 Single Dose Amino Acid Solution
4.1.3 Carbohydrates
4.1.4 Trace Elements
4.1.5 Vitamins and Minerals
4.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Type
4.2.1 Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Type (2020-2031)
4.2.3 Global Home Parenteral Nutrition (HPN) Sales Volume Share by Type (2020-2031)
4.3 Global Home Parenteral Nutrition (HPN) Sales Value by Type
4.3.1 Global Home Parenteral Nutrition (HPN) Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Home Parenteral Nutrition (HPN) Sales Value by Type (2020-2031)
4.3.3 Global Home Parenteral Nutrition (HPN) Sales Value Share by Type (2020-2031)
5 Home Parenteral Nutrition (HPN) Market by Application
5.1 Home Parenteral Nutrition (HPN) Application Introduction
5.1.1 Neonates
5.1.2 Chronic Disease Patients
5.1.3 Geriatrics
5.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Application
5.2.1 Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Home Parenteral Nutrition (HPN) Sales Volume by Application (2020-2031)
5.2.3 Global Home Parenteral Nutrition (HPN) Sales Volume Share by Application (2020-2031)
5.3 Global Home Parenteral Nutrition (HPN) Sales Value by Application
5.3.1 Global Home Parenteral Nutrition (HPN) Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Home Parenteral Nutrition (HPN) Sales Value by Application (2020-2031)
5.3.3 Global Home Parenteral Nutrition (HPN) Sales Value Share by Application (2020-2031)
6 Home Parenteral Nutrition (HPN) Regional Sales and Value Analysis
6.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2020-2031)
6.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2020-2025
6.2.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2026-2031)
6.3 Global Home Parenteral Nutrition (HPN) Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Home Parenteral Nutrition (HPN) Sales Value by Region (2020-2031)
6.4.1 Global Home Parenteral Nutrition (HPN) Sales Value by Region: 2020-2025
6.4.2 Global Home Parenteral Nutrition (HPN) Sales Value by Region (2026-2031)
6.5 Global Home Parenteral Nutrition (HPN) Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
6.6.2 North America Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
6.7.2 Europe Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
6.8.2 Asia-Pacific Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
6.9.2 South America Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value (2020-2031)
6.10.2 Middle East & Africa Home Parenteral Nutrition (HPN) Sales Value Share by Country, 2024 VS 2031
7 Home Parenteral Nutrition (HPN) Country-level Sales and Value Analysis
7.1 Global Home Parenteral Nutrition (HPN) Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Home Parenteral Nutrition (HPN) Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Home Parenteral Nutrition (HPN) Sales by Country (2020-2031)
7.3.1 Global Home Parenteral Nutrition (HPN) Sales by Country (2020-2025)
7.3.2 Global Home Parenteral Nutrition (HPN) Sales by Country (2026-2031)
7.4 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2020-2031)
7.4.1 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2020-2025)
7.4.2 Global Home Parenteral Nutrition (HPN) Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.5.2 USA Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.6.2 Canada Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.8.2 Germany Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.9.2 France Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.9.3 France Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.11.2 Italy Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.12.2 Spain Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.13.2 Russia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.16.2 China Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.16.3 China Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.17.2 Japan Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.19.2 India Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.19.3 India Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.20.2 Australia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.24.2 Chile Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.26.2 Peru Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.28.2 Israel Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.29.2 UAE Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.31.2 Iran Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Home Parenteral Nutrition (HPN) Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Home Parenteral Nutrition (HPN) Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 B. Braun Melsungen
8.1.1 B. Braun Melsungen Comapny Information
8.1.2 B. Braun Melsungen Business Overview
8.1.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.1.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
8.1.5 B. Braun Melsungen Recent Developments
8.2 Grifols International
8.2.1 Grifols International Comapny Information
8.2.2 Grifols International Business Overview
8.2.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.2.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
8.2.5 Grifols International Recent Developments
8.3 Otsuka Pharmaceutical
8.3.1 Otsuka Pharmaceutical Comapny Information
8.3.2 Otsuka Pharmaceutical Business Overview
8.3.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.3.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
8.3.5 Otsuka Pharmaceutical Recent Developments
8.4 Sichuan Kelun Pharmaceutical
8.4.1 Sichuan Kelun Pharmaceutical Comapny Information
8.4.2 Sichuan Kelun Pharmaceutical Business Overview
8.4.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.4.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
8.4.5 Sichuan Kelun Pharmaceutical Recent Developments
8.5 Teva Pharmaceutical
8.5.1 Teva Pharmaceutical Comapny Information
8.5.2 Teva Pharmaceutical Business Overview
8.5.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.5.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
8.5.5 Teva Pharmaceutical Recent Developments
8.6 Baxter
8.6.1 Baxter Comapny Information
8.6.2 Baxter Business Overview
8.6.3 Baxter Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.6.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
8.6.5 Baxter Recent Developments
8.7 Fresenius Kabi
8.7.1 Fresenius Kabi Comapny Information
8.7.2 Fresenius Kabi Business Overview
8.7.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.7.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
8.7.5 Fresenius Kabi Recent Developments
8.8 Pfizer
8.8.1 Pfizer Comapny Information
8.8.2 Pfizer Business Overview
8.8.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.8.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
8.8.5 Pfizer Recent Developments
8.9 Takeda
8.9.1 Takeda Comapny Information
8.9.2 Takeda Business Overview
8.9.3 Takeda Home Parenteral Nutrition (HPN) Sales, Value and Gross Margin (2020-2025)
8.9.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Home Parenteral Nutrition (HPN) Value Chain Analysis
9.1.1 Home Parenteral Nutrition (HPN) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Home Parenteral Nutrition (HPN) Sales Mode & Process
9.2 Home Parenteral Nutrition (HPN) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Home Parenteral Nutrition (HPN) Distributors
9.2.3 Home Parenteral Nutrition (HPN) Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.